Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousLiver TransplantationBone Marrow TransplantationKidney TransplantationTransplantation ConditioningStem Cell TransplantationHeart TransplantationGraft SurvivalMultiple MyelomaLung TransplantationPeripheral Blood Stem Cell TransplantationTreatment OutcomeCell TransplantationMelphalanHematopoietic Stem Cell MobilizationCombined Modality TherapyOrgan TransplantationGraft vs Host DiseaseBlood Transfusion, AutologousGraft RejectionLymphoma, Non-HodgkinRecurrencePancreas TransplantationIslets of Langerhans TransplantationAntigens, CD34Tissue DonorsBone Marrow PurgingSalvage TherapyTransplantation ImmunologyWhole-Body IrradiationTransplantationImmunosuppressive AgentsCyclophosphamideCarmustineRetrospective StudiesRemission InductionAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsTime FactorsTransplantation ChimeraGranulocyte Colony-Stimulating FactorLeukapheresisSurvival AnalysisHematologic NeoplasmsBusulfanDisease-Free SurvivalTransplantation, IsogeneicSurvival RateFollow-Up StudiesEtoposideHodgkin DiseaseLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationCytarabineHeart-Lung TransplantationMyeloablative AgonistsImmunosuppressionBone MarrowCells, CulturedTransplantation ToleranceGraft vs Tumor EffectTissue and Organ ProcurementHistocompatibility TestingPrognosisSkin TransplantationPostoperative ComplicationsFetal Tissue TransplantationLiver FailureMesenchymal Stem Cell TransplantationLeukemiaCell SeparationBone Marrow CellsT-LymphocytesFeasibility StudiesHematopoiesisVincristineThalidomideBlood Component RemovalTransplantation, HeterologousLymphomaTissue TransplantationLeukemia, Myeloid, AcuteStem CellsProspective StudiesFlow CytometryPrednisoneHistocompatibilityKanamycin KinaseNeoplasm, ResidualAntibodies, MonoclonalWaiting ListsGenetic TherapyCorneal TransplantationCell DifferentiationMyelodysplastic SyndromesCyclosporineColony-Forming Units Assay